Adding a daily fish oil supplement to psychotherapy showed no significant benefit over placebo for kids and teens with ...

Gilgamesh Pharma, a clinical-stage neuroscience company focused on transforming psychiatric treatment, today announced positive topline results from its Phase 2a study of blixeprodil (GM-1020).

In a major shift for how mental health conditions might be treated, the US Food and Drug Administration (FDA) has approved ...

An analysis of major depressive disorder, covering diagnostic criteria, prevalence statistics across demographics, and ...

Switzerland: A randomized trial has found that adding a daily fish oil supplement to psychotherapy did not provide any ...

Just one dose of psilocybin significantly improved depression symptoms and functional disability in patients with major depressive disorder (MDD), a randomized trial found. Administered with ...

The major depressive disorder failure for BHV-7000 is the drug's second, after Biohaven’s spinocerebellar ataxia treatment ...

Dealing with mental health conditions like depression can be challenging. Some people struggle to find the right treatment or combination of treatments for their condition. In major depression ...